Blueprint Medicines Corporation (BPMC) Financials

BPMC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.0 billion 918.6 million
2023-09-30 1.1 billion 902.7 million
2023-06-30 1.1 billion 795.3 million
2023-03-31 1.2 billion 806.1 million

BPMC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -83.6 million 22.6 million
2023-09-30 -110.7 million 23.1 million
2023-06-30 -133.0 million 23.8 million
2023-03-31 -125.5 million 23.2 million

BPMC Net Income

No data available :(

BPMC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 710.6 million - 93.7 million
2023-09-30 827.2 million - 95.7 million
2023-06-30 836.6 million 531.1 million 98.3 million
2023-03-31 961.3 million 535.3 million 100.8 million

BPMC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 60.9 million
2023-09-30 60.7 million
2023-06-30 60.5 million
2023-03-31 60.1 million

BPMC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 4.7 million 96.0 million 79.3 million -
2023-09-30 6.3 million 110.3 million 57.7 million 13.1 million
2023-06-30 2.6 million 110.1 million 53.2 million 18.7 million
2023-03-31 2.6 million 112.1 million 71.0 million -

BPMC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 72.0 million 1.8 million
2023-09-30 56.6 million 4.6 million
2023-06-30 57.6 million 2.3 million
2023-03-31 63.3 million 3.2 million

BPMC

Price: $93

52 week price:
42.26
101.00

Earnings Per Share: -8.37 USD

P/E Ratio: -8.65

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 807200

Ebitda: -37.3 million

Market Capitalization: 5.6 billion

Links: